Begin the Phase 2a proof of concept clinical study of FMX114 in atopic dermatitis
Delivered after the deadline (19 days after the deadline)
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 1 Mar 2021
- Due
- 30 Sep 2021
- Delivered
- 19 Oct 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Phase 2a clinical study in AD expected to begin in 3Q 2021”
What we found
Evidence strength A What the grades mean
The first patient was enrolled in the FMX114 atopic dermatitis trial on October 19, 2021, after the 3Q 2021 deadline. The trial is described as Phase 1b/2a.
-
A VYNE Therapeutics Inc. 8-K filed 2021-10-19
“The planned 25 patient Phase 2a study comparing the safety and efficacy of FMX114 gel with vehicle gel will also incorporate a preliminary Phase 1b evaluation” ✓ confirmed on the page
-
A VYNE Therapeutics Inc. 10-Q filed 2021-11-10
“On October 19, 2021, we announced that the first patient was enrolled in our Phase 1b/2a clinical trial evaluating FMX114 for the treatment of mild-to-moderate atopic dermatitis.” ✓ confirmed on the page
-
A VYNE Therapeutics Inc. 10-Q filed 2021-11-10
“We expect to continue to invest in FMX114 for the treatment of mild to moderate atopic dermatitis and enrolled the first patient in our Phase 1b/2a proof-of-concept study in October 2021.” ✓ confirmed on the page
Checked 27 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Begin
- Deliverable
- Phase 2a proof of concept study of FMX114
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you VYNE Therapeutics Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-YARW-024804 · Corrections policy